Compared to opioid pain management, peptide therapy carries no dependency or addiction potential, no respiratory depression risk, no tolerance development, and no overdose risk
Sublingual troches: Typical dose: 50-200mcg per troche Frequency: 1-2 times daily Administration: Dissolve between cheek and gum for 15-20 minutes Absorption: Bypasses first-pass liver metabolism through oral mucosa Liposomal oral: Typical dose: 100-500mcg Frequency: Once daily Note: Lipid encapsulation protects peptide through digestion Oral forms suit those unwilling to inject who still want systemic rather than purely local effects
(This can include certain chemicals, acids, botanicals, metals, and more.) Allergens usually cause a shiny, blistered, itchy rash, while irritants tend to cause a dry, scaly, less itchy rash
Methionine synthase and Methylmalonyl-CoA mutase
Great question